Findings suggest new approach to treating Alzheimer’s, other neurodegenerative diseases
Gut bacteria affect brain health, mouse study shows
Author: The SOURCE/Medicine & Health
WashU, Eisai form drug discovery collaboration
Focus is on therapies for Alzheimer’s, other neurodegenerative diseases
Immunotherapy eliminates disease-causing cells in mice with MS-like disease
Successful cancer treatment approach extended to autoimmune disease
Study yields clues to why Alzheimer’s disease damages certain parts of the brain
Findings could help explain rare symptoms such as problems with language, vision
Rejuvenated immune cells can improve clearance of toxic waste from brain
Findings in mice suggest new therapeutic approach to Alzheimer’s, other age-related diseases
Cellular housekeeping process implicated in fatal neurological disorder
Neurons made from Huntington’s disease patients’ skin cells shed light on cognitive decline
New strategy shows potential to block nerve loss in neurodegenerative diseases
Research into how key molecule triggers axon death may lead to new therapies
Scientists ID pathway that triggers mice to scratch when they see others do the same
Behavior surprisingly does not require brain’s visual cortex
Investigational drug for genetic form of ALS improves disease’s molecular signs
Extended use of tofersen may help stabilize muscle strength, control
New center’s aim: To ID biomarkers of neurodegenerative diseases
A new center established at Washington University School of Medicine in St. Louis aims to accelerate research into biomarkers of neurodegenerative conditions such as Huntington’s and Parkinson’s diseases, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and the so-called tauopathies, a group that includes Alzheimer’s disease along with rarer diseases such as frontotemporal dementia, corticobasal syndrome […]
Protein linked to intellectual disability has complex role
Finding therapies for fragile X may depend on understanding the many ways protein’s loss affects brain
Diabetes, metabolic syndrome in mice treated with novel class of compounds
Improves insulin secretion, lowers blood sugar
Emotional aspects of chronic pain isolated in brain circuitry
Animal study could help ID new treatment targets for negative emotions linked to pain
‘Fight or flight’ – unless internal clocks are disrupted, study in mice shows
For humans and animals, many aspects of normal behavior and physiology rely on the proper functioning of the body’s circadian clocks.
Cannabis use disorder: another COVID risk factor
Research indicates problematic marijuana use is correlated with poorer COVID-19 outcomes
New Alzheimer’s treatment targets identified
Study points to FDA-approved drugs that have potential to slow or reverse brain damage
New snack foods nurture healthy gut microbiome
Microbiome-modifying foods designed with specific combinations of plant fibers
WashU, Pitt awarded $10.7 million for Alzheimer’s disease research
Study to look for genetic pathways that lead to formation of plaques, tangles
For malnourished children, a new type of microbiome-directed food boosts growth
New food is designed to nurture healthy gut microbes
Chemo for glioblastoma may work better in morning than evening
Study indicates timing of chemotherapy could improve treatment for deadly brain cancer
Zika virus helps destroy deadly brain cancer in mice
Virus-based therapy may unlock potential of immunotherapy for glioblastoma
Brain rewires itself after injury ‘on the edge of what’s compatible with life’
Stroke suffered as newborn went undetected for 13 years
International Alzheimer’s clinical trial to test tau drugs
Antibody is first of three tau drugs to be evaluated